GoodRx vs Remedy Meds
GoodRx costs $150 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between GoodRx and Remedy Meds, the first difference is cost: GoodRx is $150 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 5.1. One of the two has an FDA warning letter on record, covered below.
GoodRx vs Remedy Meds price
GoodRx is the cheaper way in: $149 a month against $299 a month at Remedy Meds. That is $150 less each month (50% lower), or about $1,800 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at GoodRx ($299 a month vs $399 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Remedy Meds lists semaglutide.
On format, GoodRx prices brand-name pens, while Remedy Meds prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Remedy Meds does not publish where it ships.
Pricing
GoodRx
Remedy Meds
What each price covers
Remedy Meds' price also covers the clinician visit, the medication itself and shipping, which GoodRx does not claim.
GoodRx does not say what its price includes.
Remedy Meds is silent on lab work and coaching.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
Remedy Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, GoodRx scores 6.9 and Remedy Meds 5.1 out of 10.
GoodRx is stronger on value (5.0 vs 3.0), user experience (5.0 vs 3.0), trust & safety (6.0 vs 1.0) and accessibility (10.0 vs 5.0).
Remedy Meds is stronger on support (7.0 vs 5.0).
Effectiveness is within half a point.
GoodRx
6.9/10
Remedy Meds
5.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Remedy Meds a warning letter dated September 9, 2025 (letter 716830), and it is still open.
GoodRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Remedy Meds |
|---|---|---|
| Starting Price | ✓$149/mo | $299/mo |
| Features | ✓6 features | 3 features |
| States Available | 50 | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Remedy Meds
Remedy Meds sells compounded semaglutide and tirzepatide programs through telehealth.
Read our full Remedy Meds review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Remedy Meds
What we like
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Remedy Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 5.1, above all for oral orforglipron alongside the injectables. It also costs $150 less each month than Remedy Meds.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Remedy Meds if…
You want broader feature coverage and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →GoodRx vs Remedy Meds: FAQ
Close alternatives to GoodRx and Remedy Meds
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Remedy Meds vs Willow
- Remedy Meds vs Apex MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.